Several studies indicate that aberrant expression of SMAD6, a negative regulator of TGF-α signaling, affects homeostasis of the cardiovascular system [58, 59] and plays a role in obesity in a mouse model [60]. This evidence concerns the gene SMAD6 and obesity disorder.